Meet an Unreasonable Venture
CyanoCapture
Bringing affordable carbon capture to emitting industries worldwide.
CyanoCapture is using a genetically engineered microbe to make CO2 low-cost for emission sites. The company currently holds patents on the world’s fastest photosynthetic organism for CO₂ fixation and has developed methods to convert CO₂ into battery graphite and high-value compounds for biopharma. In December 2024, CyanoCapture created a strain that can make recombinant insulin out of CO2, paving the way for low-cost carbon-negative biomanufacturing to be possible.
Notable Achievements
- Raised $4.49M in equity financing from VCs and angels and a further $5M in non-dilutive prizes.
- Secured a 12-month partnership with L’Oréal (2025).
- First company in the world to successfully turn CO2 into insulin using photosynthesis.
Currently Operating in One Region
More Ventures in Energy & Environment
Get the Unreasonable Newsletter
Get monthly updates on CyanoCapture and all of the other ventures working to solve the world's toughest problems.